Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iso-Osmolar vs. Low-Osmolar Contrast Agents for OCT
NCT05065073Phase 4Completed
- Sponsor
- Minneapolis Heart Institute Foundation
- Start
- Sep 2021
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
A Phase 4 trial of iodixanol, iohexol in coronary artery disease (CAD), sponsored by Minneapolis Heart Institute Foundation. Started Sep 2021; status: completed.
02
Drugs
iodixanoliohexol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05065073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065073.